The efforts from pharmacy organizations follow the Food and Drug Administration recently authorizing the first post-exposure prophylaxis for COVID-19 emergency use.
IQVIA’s Doug Long and Scott Biggs weighed in on trends, issues and forecasts for the pharmacy industry as the country begins to emerge from the pandemic and navigate a new normal.
Tofacitinib extended-release tablets are indicated to treat moderate to severely active rheumatoid arthritis in those whom methotrexate did not work well or cannot be tolerated.
DSN talks to Camber Pharmaceuticals president Kon Ostaficiuk about the company's pandemic efforts and the recent additions to its pharmaceutical and store-brand OTC offerings.
